Skip to content

Research on the Role and Mechanisms of tRF&tiRNA in Cervical Cancer

Research on the Role and Mechanisms of tRF&tiRNA in Cervical Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117927
Enrollment
Unknown
Registered
2026-01-30
Start date
2025-07-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Sponsors

The First Hospital of Northwest University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.None of them received any radiotherapy, chemotherapy or hormone therapy before the operation. 2.All specimens were pathologically diagnosed as cervical squamous cell carcinoma, and the adjacent normal tissues were confirmed by pathologists to have no benign or malignant tumors of any type; 3.All patients' clinical and pathological data as well as the results of ultrasound examinations were complete. Pathological diagnoses were confirmed by at least two senior pathologists.

Exclusion criteria

Exclusion criteria: 1.Those who have had any previous history of gynecological tumor surgery; 2.Those with concurrent infectious diseases, autoimmune system disorders, other malignant tumors or significant organic lesions.

Design outcomes

Primary

MeasureTime frame
tRF & tiRNA Expression Profile;

Countries

China

Contacts

Public ContactHao Jing

The First Hospital of Northwest University

80543840@qq.com+86 29 8262 6314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026